Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Immunogenic
100%
H1N1 Vaccine
100%
Older Adults
100%
Elderly Adults
100%
2009 H1N1
100%
Well Tolerated
100%
Super-elderly
87%
95% Confidence Interval
50%
Adult Age
37%
Hemagglutination Inhibition
37%
Old Age
12%
Placebo
12%
Young Age
12%
Randomized Placebo-controlled Trial
12%
All Ages
12%
H1N1
12%
Clinical Trials
12%
Phase II Trial
12%
2-dose
12%
Antibody Level
12%
Vaccination
12%
Trial Registration
12%
Monovalent Cations
12%
Hemagglutinin
12%
Geometric Mean Titer
12%
Hemagglutination Inhibition Antibody
12%
Influenza A
12%
Novel H1N1 Influenza
12%
Novel H1N1
12%
Vaccine Response
12%
Public Health Priorities
12%
Nursing and Health Professions
Confidence Interval
100%
Single Drug Dose
100%
Placebo
50%
Post Hoc Analysis
25%
Health Care Planning
25%
Influenza A (H1N1)
25%
Hemagglutination Inhibiting Antibody
25%
Hemagglutinin
25%
Public Health
25%
Clinical Trial
25%
Medicine and Dentistry
Single Drug Dose
100%
Influenza A Virus (H1N1)
100%
Hemagglutination Inhibition
50%
Placebo
33%
Public Health
16%
Clinical Trial
16%
Hemagglutination Inhibiting Antibody
16%
Post-Hoc Analysis
16%
Influenza A (H1N1)
16%
Hemagglutinin
16%
Immunology and Microbiology
Influenza A Virus (H1N1)
100%
Titer
57%
Hemagglutination Inhibition
42%
Influenza
14%
Hemagglutination Inhibiting Antibody
14%
Hemagglutinin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Influenza A Virus (H1N1)
100%
Placebo
33%
Clinical Trial
16%
Influenza A (H1N1)
16%
Hemagglutinin
16%
Hemagglutination Inhibiting Antibody
16%
Vaccination
16%